Asciminib
About
Therapy type: Targeted therapy
Therapy strategy: BCR-ABL inhibition
Mappings
NCI Thesaurus: Asciminib (coding:ncit:C114494)
RxNorm: asciminib (coding:rxcui:2584304, coding:omop:702133)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (1) FDA (4) | BCR::ABL1 | Chronic Myeloid Leukemia, BCR-ABL1+ | Asciminib | |
| EMA (1) FDA (2) | ABL1 p.T315I, BCR::ABL1 | Chronic Myeloid Leukemia, BCR-ABL1+ | Asciminib |